| | | | | | | | | | |
|
|
| Dockets Entered
On September 21, 2007
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
| 1995S-0158
|
| Community Disclosure of Institutional Review Boards
|
|
|
| 1996N-0417
|
| CGMP in Mfg. Packing or Holding Dietary Supplements
|
|
|
| 2005N-0353
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Pharmaceutical Development Study
|
|
|
| 2006N-0454
|
| Use of Ozone-Depleting Substances; Removal of Essential-Use Designations
|
|
|
| 2007N-0262
|
| Use of Ozone-Depleting Substances; Removal of Essential-Use Designation (Epinephrine)
|
|
|
| 2007N-0277
|
| Food Labeling: Use of Symbols to Communicate Nutrition Information, Consideration of Consumer Studies and Nutritional Criteria; Public Hearing
|
|
|
| 2007N-0337
|
| Agency Information Collection Activities: Proposed Collection; Comment Request; Radioactive Drug Research Committees
|
|
|
| 2007N-0347
|
| Information Technology Strategic Planning; Public Meeting
|
|
|
| 2007P-0354
|
| Refrain from approving Any Application for a Generic Thalidomide Product
|
|
|
| 1995S-0158
|
| Community Disclosure of Institutional Review Boards
|
|
|
| RPT 24
|
| ROC
|
| Vol #:
|
| 58
|
|
|
| 1996N-0417
|
| CGMP in Mfg. Packing or Holding Dietary Supplements
|
|
|
| C 283
|
| Norman Kjome
|
| Vol #:
|
| 54
|
|
|
| C 284
|
| J & V Small
|
| Vol #:
|
| 54
|
|
|
| LET 1
|
| Norman Kjome
|
| Vol #:
|
| 54
|
|
|
| 2005N-0353
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Pharmaceutical Development Study
|
|
|
| NAL 1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2006N-0454
|
| Use of Ozone-Depleting Substances; Removal of Essential-Use Designations
|
|
|
| C 2558
|
| R Henry
|
| Vol #:
|
| 27
|
|
|
| C 2559
|
| B Weber
|
| Vol #:
|
| 27
|
|
|
| C 2560
|
| M Pointer
|
| Vol #:
|
| 27
|
|
|
| C 2561
|
| G Barnes Jr
|
| Vol #:
|
| 27
|
|
|
| C 2562
|
| N Hart
|
| Vol #:
|
| 27
|
|
|
| C 2563
|
| M Sherin
|
| Vol #:
|
| 27
|
|
|
| C 2564
|
| N Laughman
|
| Vol #:
|
| 27
|
|
|
| C 2565
|
| S. Barbe
|
| Vol #:
|
| 27
|
|
|
| C 2566
|
| B Polk
|
| Vol #:
|
| 27
|
|
|
| C 2567
|
| K Mundloch
|
| Vol #:
|
| 27
|
|
|
| C 2568
|
| D Monnig
|
| Vol #:
|
| 27
|
|
|
| C 2569
|
| P Stambler
|
| Vol #:
|
| 27
|
|
|
| C 2570
|
| L Davis
|
| Vol #:
|
| 27
|
|
|
| C 2571
|
| J Bennett Sr
|
| Vol #:
|
| 27
|
|
|
| C 2572
|
| D Lysne
|
| Vol #:
|
| 27
|
|
| | | | | | | | |
|
|
| C 2610
|
| J Branham
|
| Vol #:
|
| 27
|
|
|
| C 2611
|
| E Fry
|
| Vol #:
|
| 27
|
|
|
| C 2612
|
| J Reid
|
| Vol #:
|
| 27
|
|
|
| C 2613
|
| M Burrell
|
| Vol #:
|
| 27
|
|
|
| C 2614
|
| J Gutierrez
|
| Vol #:
|
| 27
|
|
|
| C 2615
|
| J Blount
|
| Vol #:
|
| 27
|
|
|
| C 2616
|
| S Blair
|
| Vol #:
|
| 27
|
|
|
| C 2617
|
| G Smiley
|
| Vol #:
|
| 27
|
|
|
| C 2618
|
| W Tuck
|
| Vol #:
|
| 27
|
|
|
| C 2619
|
| W Isle
|
| Vol #:
|
| 27
|
|
|
| C 2620
|
| J Pierce
|
| Vol #:
|
| 27
|
|
|
| C 2621
|
| B Shafer
|
| Vol #:
|
| 27
|
|
|
| C 2622
|
| C Hatcher
|
| Vol #:
|
| 27
|
|
|
| C 2623
|
| P Edminister
|
| Vol #:
|
| 27
|
|
|
| C 2624
|
| V Michael
|
| Vol #:
|
| 27
|
|
|
| 2007N-0262
|
| Use of Ozone-Depleting Substances; Removal of Essential-Use Designation (Epinephrine)
|
|
|
| REF 1
|
| OMB Review held on September
20, 2007
|
| Vol #:
|
| 1
|
|
|
| 2007N-0277
|
| Food Labeling: Use of Symbols to Communicate Nutrition Information, Consideration of Consumer Studies and Nutritional Criteria; Public Hearing
|
|
|
| C 1
|
| National Restaurant Association
|
| Vol #:
|
| 1
|
|
|
| 2007N-0337
|
| Agency Information Collection Activities: Proposed Collection; Comment Request; Radioactive Drug Research Committees
|
|
|
| N 1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2007N-0347
|
| Information Technology Strategic Planning; Public Meeting
|
|
|
| NM 1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2007P-0354
|
| Refrain from approving Any Application for a Generic Thalidomide Product
|
|
|
| ACK 1
|
| FDA/DDM to Sidley Austin LLP
|
| Vol #:
|
| 1
|
|
|
| CP 1
|
| Celgene Corporation
|
| Vol #:
|
| 1
|
|